Last update:

Arthritis & Rheumatism news

Arthritis & Rheumatism

Study offers potential for early diagnosis and therapeutic intervention for rheumatoid arthritis

Currently, there are no cures for rheumatoid arthritis (RA), which affects 40,000 people in Ireland. The disease costs an estimated $22,000 per patient, per year with an overall cost to the health system of ~$608 million. ...

Arthritis & Rheumatism

AI chatbots rival doctors in accuracy for back pain advice, study finds

A new study reveals that artificial intelligence chatbots, such as ChatGPT, may be almost as effective as consulting a doctor for advice on low back pain.

Arthritis & Rheumatism

Study shows AFL players' hip issues begin in early career

Researchers from La Trobe University studied 58 pain-free male Australian Football League (AFL) draftees, finding that nearly half showed hip joint changes on Magnetic Resonance Imaging (MRI) and 20% had a particular hip ...

Arthritis & Rheumatism

Study uncovers key factors in myositis-induced muscle weakness

A study has shed new light on the mechanisms behind idiopathic inflammatory myopathies (myositis), a group of systemic autoimmune disorders known for causing severe muscle weakness, fatigue, and increased mortality.

Arthritis & Rheumatism

Machine learning helps identify rheumatoid arthritis subtypes

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to improve care ...

Arthritis & Rheumatism

Surprising mechanism of lupus kidney damage identified

A Berlin-led research team has uncovered critical regulators of severe kidney damage in patients with lupus, an autoimmune disorder affecting an estimated five million people worldwide, most of whom are young women. A small, ...

Arthritis & Rheumatism

Etanercept reduces work, activity impairment in RA

(HealthDay)—For patients with moderate-to-severe rheumatoid arthritis (RA), continued etanercept treatment is associated with reduced work and activity impairment, according to a study published online April 1 in Arthritis ...

Arthritis & Rheumatism

Low-income patients skip rheumatoid arthritis meds

(HealthDay)—Electronic monitoring shows that ethnically diverse and economically disadvantaged patients with rheumatoid arthritis (RA) have low adherence to oral disease-modifying antirheumatic drugs (DMARDs) and poorer ...

Arthritis & Rheumatism

Model recreates wear and tear of osteoarthritis

(Medical Xpress)—There's a reason osteoarthritis is often called wear-and-tear arthritis: Repeated stress on joints over time results in degeneration of the soft cartilage that normally distributes loads to the joints.

Arthritis & Rheumatism

Novel biomarkers improve diagnosis in rheumatoid arthritis

Data presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, show that novel antibody biomarkers could significantly improve diagnosis in rheumatoid arthritis (RA).

Arthritis & Rheumatism

Nurse-led programs help patients self-manage RA

Data first presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism demonstrate the benefits of a nurse-led programme on patient self-management and the management of rheumatoid arthritis ...

Arthritis & Rheumatism

Childbirth increases risk of ACPA-negative rheumatoid arthritis

Epidemiological data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate that pregnancy carried to childbirth (parity) increases the risk of ACPA-negative* rheumatoid ...

Arthritis & Rheumatism

Abatacept as effective as adalimumab in rheumatoid arthritis

Data from AMPLE presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate comparable efficacy and similar safety profiles between subcutaneous abatacept (ABA) and adalimumab (ADA).